Among CRC patients with high microbial SphK2 activity, combination therapy induced a significant expansion of effector memory CD8+ T cells within the tumor microenvironment, accompanied by a relative reduction in Tex cell subsets. This evidence concerns the gene CD8A and neoplasm.